Deluxe Reports Strong 2025 Financial Performance, Raises 2026 Outlook, and Boosts Free Cash Flow

summarizeSummary

Deluxe Corporation reported strong financial results for the fourth quarter and full year 2025, exceeding prior year performance across key metrics and significantly increasing free cash flow. The company also provided an optimistic outlook for 2026, projecting continued growth in earnings and free cash flow.

check_boxKey Events

• Strong Full-Year 2025 Financial Performance

  Deluxe reported a 61.2% increase in net income to $85.3 million and a 58.5% rise in GAAP diluted EPS to $1.87 for the full year 2025. Comparable adjusted diluted EPS grew 12.6% to $3.67, while comparable adjusted revenue increased 1.1%.

• Significant Free Cash Flow Growth and Debt Reduction

  Free cash flow increased by $75.3 million to $175.3 million in 2025. The company also reduced total debt by $73.7 million and net debt by $76.2 million, improving its leverage ratio ahead of schedule.

• Positive 2026 Financial Outlook

  For full year 2026, Deluxe expects adjusted diluted EPS of $3.90 to $4.30 (up from $3.67 in 2025), adjusted EBITDA of $445 to $470 million (up from $431.5 million in 2025), and free cash flow of approximately $200 million (up from $175.3 million in 2025).

• Quarterly Dividend Maintained

  The Board of Directors approved a regular quarterly dividend of $0.30 per share, payable on February 23, 2026.

auto_awesomeAnalysis

Deluxe Corporation delivered robust financial results for the full year 2025, marked by significant increases in net income, GAAP diluted EPS, and comparable adjusted diluted EPS. The company also demonstrated strong operational execution by generating substantial free cash flow and reducing its total and net debt ahead of schedule. The positive momentum is expected to continue into 2026, with management providing an optimistic outlook for adjusted EBITDA, adjusted diluted EPS, and free cash flow. This performance, coupled with the maintained quarterly dividend, reinforces the company's financial health and strategic execution, which is particularly notable as the stock trades near its 52-week high.